Cancer news
Researchers 'notch' a victory toward new kind of cancer drug
7 hours ago |
5 / 5 (1) |
0
Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in the November 12 issue ...
Researchers find a weak link in cancer cell armor
13 hours ago |
5 / 5 (3) |
0
(PhysOrg.com) -- Professor Robert Weiss has found that when two particular genes are inhibited, cancer cells are destroyed at a greater rate. The study is published in the Nov. 9 issue of PNAS.
Drug shrinks lung cancer tumors in mice
Nov 10, 2009 |
4.8 / 5 (6) |
0
(PhysOrg.com) -- A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer ...
New mechanism explains how the body prevents formation of blood vessels
11 hours ago |
4 / 5 (1) |
0
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Inhibiting ...
Drugs to treat anemia in cancer patients linked to thromboembolism
Nov 10, 2009 |
2.5 / 5 (2) |
1
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., ...
FDA approved leukemia drugs shows promise in ovarian cancer cells
Nov 10, 2009 |
not rated yet |
0
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, ...
Routine evaluation of prostate size not as effective in cancer screening (w/ Video)
Nov 10, 2009 |
not rated yet |
0
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development ...
Antitumor activity of nutlin-3 in neuroblastoma with wild-type p53
Nov 10, 2009 |
not rated yet |
0
The small-molecule inhibitor nutlin-3 may be a viable treatment option for neuroblastoma patients with wild-type p53 activity, according to a new study published online November 10 in the Journal of the National Cancer In ...
Persistent pain common for many women 2 to 3 years after breast cancer treatment
Nov 10, 2009 |
not rated yet |
0
Nearly 50 percent of women surveyed indicate they experience pain symptoms 2 to 3 years after breast cancer treatment, with women who were younger or who received supplemental radiation therapy more likely to have pain, according ...
Men leave: Separation and divorce far more common when the wife is the patient
Nov 10, 2009 |
5 / 5 (1) |
0
A woman is six times more likely to be separated or divorced soon after a diagnosis of cancer or multiple sclerosis than if a man in the relationship is the patient, according to a study that examined the role gender played ...
Minimally invasive surgery shown safe and effective treatment for rectal cancer
Nov 10, 2009 |
not rated yet |
0
Laparoscopic surgery has been used in the treatment of intestinal disorders for close to 20 years, but its benefits have only recently begun to be extended to people with rectal cancer. In a prospective study of 103 patients ...
Age-specific evaluation of HPV DNA testing vs. cytology screening
Nov 10, 2009 |
not rated yet |
0
Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of th ...
Detecting overall survival benefit derived from progression-free survival
Nov 10, 2009 |
not rated yet |
0
Overall survival (OS) may be a reasonable primary endpoint when the median survival postprogession (SSP) is less than 6 months, but it is too high a hurdle when SPP is longer than 12 months, according to a new study published ...
- Pages: 1
